MENU
+Compare
GNTA
Stock ticker: NASDAQ
AS OF
Sep 26, 03:26 PM (EDT)
Price
$3.16
Change
+$0.04 (+1.28%)
Capitalization
57.15M

GNTA Genenta Science SpA Forecast, Technical & Fundamental Analysis

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer... Show more

GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GNTA with price predictions
Sep 25, 2025

GNTA's RSI Oscillator ascending out of oversold territory

The RSI Indicator for GNTA moved out of oversold territory on September 12, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where GNTA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 25, 2025. You may want to consider a long position or call options on GNTA as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GNTA just turned positive on September 25, 2025. Looking at past instances where GNTA's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNTA advanced for three days, in of 144 cases, the price rose further within the following month. The odds of a continued upward trend are .

GNTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

GNTA moved below its 50-day moving average on September 02, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.871) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GNTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Via Olgettina No. 58
Phone
+39 226434681
Employees
14
Web
https://www.genenta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPTHF0.210.02
+10.46%
OPTIMI HEALTH CORP.
EDCFF0.20N/A
N/A
ENEL GENERACION COSTANERA S A
ACDSF2.21N/A
N/A
Ascendas Real Estate Investment Trust
CSLUF11.59N/A
N/A
CSLM Acquisition Corp.
TAVHY23.05-0.10
-0.41%
Tav Havalimanlari Holding AS

GNTA and Stocks

Correlation & Price change

A.I.dvisor tells us that GNTA and WVE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNTA and WVE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
-0.80%
WVE - GNTA
30%
Poorly correlated
-1.04%
BEIGF - GNTA
28%
Poorly correlated
N/A
DRUG - GNTA
27%
Poorly correlated
+2.69%
PTHS - GNTA
25%
Poorly correlated
-1.89%
RLFTF - GNTA
24%
Poorly correlated
-1.50%
More